VCM-64521-36678 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-29
Registered in v-safe
2022-06-29
Dose 1 — Pfizer-BioNTech
2022-06-29
Health check-in — day 0, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Irritability/crying, Diarrhea

Under 3 check-in
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-13
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-20
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-27
Dose 2 — Pfizer-BioNTech
2022-07-27
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-08-03
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-12
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-17
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-24
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-31
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-09
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-26
Survey response — 3 months, dose 2, under 3
MedDRA: Cough, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Fever, cough, congestion

MedDRA releases: 2024-11 · check-in free text available
2023-01-27
Survey response — 6 months, dose 2, under 3
MedDRA: Respiratory tract infection viral — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

MedDRA releases: 2024-11
2023-01-27
Report sent to call center — 6 months, dose 2, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
2023-01-30
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-29	Pfizer-BioNTech	No
2	2022-07-27	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2023-01-27	Successful 2023-01-30	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-10-26

Symptoms: Fever, cough, congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Respiratory tract infection viral	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release